News Releases

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Microbix Biosystems Inc. reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“Q3” and “YTD”) with strong revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and resulting in material net income for Q3 and YTD.

read more
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM

Microbix Presents HCV FLOQSwab® Format Test Control at ADLM

Microbix Biosystems Inc. introduces a novel Quality Assessment Product (QAP™) for Hepatitis C Virus (HCV) POCTs at the ADLM conference. This swab-based, room-temperature stable control aims to enhance accessibility and accuracy of HCV testing, especially in low-resource settings.

read more
Microbix Hosts Minister Nina Tangri to Open Capacity Expansions

Microbix Hosts Minister Nina Tangri to Open Capacity Expansions

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites.

read more
Microbix’s Virtual AGM

Microbix’s Virtual AGM

  Microbix will be hosting a virtual AGM on March 27, 2024, at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO presentation via...

read more
Microbix Reports Results for Q1 Fiscal 2023 – Sales of $2.5 million, Net Loss of $1.3 million

Q3 Fiscal 2020

Year-Over-Year QAPs Sales Growth of 141% for Q3 MISSISSAUGA, August 14, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator...

read more